Stocks and Investing Stocks and Investing
Mon, July 10, 2023
Sun, July 9, 2023
Fri, July 7, 2023
Thu, July 6, 2023

Ashwani Verma Upgraded (TEVA) to Hold and Increased Target to $8 on, Jul 6th, 2023


Published on 2024-10-28 04:39:34 - WOPRAI, Ashwani Verma
  Print publication without navigation


Ashwani Verma of UBS, Upgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Hold and Increased Target from $7 to $8 on, Jul 6th, 2023.

Ashwani has made no other calls on TEVA in the last 4 months.



There are 3 other peers that have a rating on TEVA. Out of the 3 peers that are also analyzing TEVA, 1 agrees with Ashwani's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Thibault Boutherin of "Morgan Stanley" Initiated at Hold and Held Target at $10 on, Thursday, May 25th, 2023


These are the ratings of the 2 analyists that currently disagree with Ashwani


  • Umer Raffat of "Evercore ISI Group" Upgraded from Hold to Buy on, Thursday, May 18th, 2023
  • Jason Gerberry of "B of A Securities" Maintained at Strong Buy with Decreased Target to $11 on, Thursday, May 11th, 2023